Pharmaceutical press releases & news - Bristol Myers Squibb
Jan 3, 2025 · Explore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines and research innovation, our partnerships, our people, and our Foundation efforts as we work to support patients fighting serious disease.
FDA approves injectable version of Bristol Myers Squibb's cancer …
Dec 27, 2024 · The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's , opens new tab blockbuster cancer drug, Opdivo.
Bristol Myers Faces Renewed, $6.7 Billion Lawsuit Over Delayed …
Nov 14, 2024 · NEW YORK (Reuters) - Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2...
Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer …
Nov 14, 2024 · Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months after a...
BioArctic announces global license agreement with Bristol Myers Squibb ...
Dec 19, 2024 · The agreement with Bristol Myers Squibb is the first license agreement with the BrainTransporter technology. It specifically concerns PyroGlu-Aβ antibody treatments. BioArctic has retained all ...
Bristol Myers Squibb - Bristol Myers Squibb Showcases the …
Nov 11, 2024 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its cardiovascular portfolio at the American Heart Association (AHA) Annual Scientific Sessions, taking place November 16-18, 2024, in Chicago, Illinois.
Bristol Myers Squibb - Bristol Myers Squibb Completes …
Mar 18, 2024 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).
Bristol Myers Squibb - Press Releases
Receive updated news from preferred websites, which are sent directly to the user's news reader. This includes the headlines, summaries and links to the full article on the website.
Bristol Myers faces renewed, $6.7 billion lawsuit over delayed …
Nov 15, 2024 · NEW YORK (Reuters) - Bristol Myers Squibb (BMY) was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs,...
BMS plans $1.5B in cuts through '25, with 2,000-plus layoffs
Apr 25, 2024 · Bristol Myers Squibb is the latest large pharma to wield the restructuring ax, with plans to cut $1.5 billion in costs by the end of 2025, including laying off more than 2,000 employees.